Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Astrocyte-to-neuron reprogramming via depletion of PTBP1, a potent repressor of neuronal splicing, has been proposed as a therapeutic strategy, but its efficacy remains debated. While some reported successful conversion, others disputed this, citing a lack of neuronal gene expression as evidence of failed reprogramming. This interpretation was further challenged, attributed to incomplete PTBP1 inactivation, fueling ongoing controversy. Mechanistic understanding of the conversion, or the lack thereof, requires investigating, in conjunction with lineage tracing, the effect of loss of function in mature astrocytes on RNA splicing, which has not yet been examined. Here, we genetically ablated PTBP1 in adult Aldh1l1-Cre/ERT2 Ai14 mice to determine whether lineage traced knockout astrocytes exhibited RNA splicing alterations congruent with neuronal differentiation. We found no widespread induction of neurons, despite a minuscule fraction of knockout cells showing neuron-like transcriptomic signatures. Importantly, PTBP1 loss in mature astrocytes induced splicing alterations unlike neuronal splicing patterns. These findings suggest that targeting PTBP1 alone is ineffective to drive neuronal reprogramming and highlight the need for combining splicing and lineage analyses. Loss of astrocytic PTBP1 is insufficient to induce neuronal splicing, contrasting with its well-known role in other non-neuronal cells, and instead affects a distinct astrocytic splicing program.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12157468PMC
http://dx.doi.org/10.1101/2025.05.30.657115DOI Listing

Publication Analysis

Top Keywords

mature astrocytes
12
splicing alterations
12
neuronal splicing
12
splicing
9
alterations neuronal
8
rna splicing
8
ptbp1
7
neuronal
7
ptbp1 depletion
4
depletion mature
4

Similar Publications

Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system (CNS) and is most often clinically presented in a relapsing form. Within MS lesions, oligodendrocyte progenitor cells (OPCs) differentiate into mature myelinating oligodendrocytes and mediate repair. A further understanding of the molecular mechanisms responsible for OPC differentiation will undoubtedly influence the direction of future treatments in MS.

View Article and Find Full Text PDF

EAAT2 dysfunction mediates acrylamide-induced excitotoxicity and neuronal damage in a SH-SY5Y/U251 co-culture model.

Toxicology

August 2025

State Key Laboratory of Trauma and Chemical Poisoning, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China. Electronic address:

Acrylamide (ACR) is a pervasive environmental and workplace contaminant with established neurotoxic effects but unclear pathogenic mechanisms. In this study, we screened for potential ACR binding targets associated with neurotoxicity and identified the astrocytic glutamate transporter EAAT2. Molecular docking and dynamics simulations revealed that ACR interacts stably with the glutamate-binding pocket of EAAT2, potentially impairing transport function.

View Article and Find Full Text PDF

Central nervous system (CNS) injury is one of the most serious public health problems worldwide. To prevent secondary cascade damages to CNS caused by dural defects, the repair of dural defects is an essential step in CNS injury treatment. Although various artificial dura maters have been developed, unfortunately, no one exerting positive therapeutic effects for CNS injury repair.

View Article and Find Full Text PDF

Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington's disease.

Acta Neuropathol Commun

August 2025

NeuroGenCell, Inserm U 1127, CNRS UMR 7225, ICM, Institut du Cerveau, Sorbonne Université, Paris, France.

Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by an abnormal expansion of cytosine-adenine-guanosine (CAG) trinucleotidein the huntingtin gene. Mutant huntingtin (mHTT) expression in neurons and glial cells affects neuron and astrocyte functions and leads to the loss of medium spiny neurons of the striatum. Brain cholesterol pathway is severely affected by HTT mutation in neurons and astrocytes, contributing to HD pathogenesis.

View Article and Find Full Text PDF

MiRNA-Mediated Regulation of S100B: A Review.

NeuroSci

August 2025

Department of Psychology and Neuroscience, DePauw University, Greencastle, IN 46135, USA.

S100β is a significant signaling molecule and biomarker that is primarily expressed in the brain. At low physiological concentrations, S100β induces astrocyte maturation, microglial migration, and neural proliferation. However, high concentrations activate inflammatory and pro-apoptotic pathways.

View Article and Find Full Text PDF